We serve Chemical Name:2-butyl-3,5-(and 3,6)-dimethyl pyrazine CAS:72797-18-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-butyl-3,5-(and 3,6)-dimethyl pyrazine
CAS.NO:72797-18-3
Synonyms:Pyrazine,2-butyl-3,-dimethyl;3,5/3,6-Dimethyl-2-isobutylpyrazine
Molecular Formula:C20H32N4
Molecular Weight:328.49500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:51.56000
Exact Mass:328.26300
LogP:4.87200
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Pyrazine,2-butyl-3,-dimethyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5/3,6-Dimethyl-2-isobutylpyrazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyrazine,2-butyl-3,-dimethyl Use and application,3,5/3,6-Dimethyl-2-isobutylpyrazine technical grade,usp/ep/jp grade.
Related News: As for the expansion itself, Takeda will build a new 15,000-square-foot manufacturing facility at the site and expand an existing 14,000-square-feet of production space. Takeda has been knocking around the Thousand Oaks area since 1996, the Business Times said. Diethyl-phosphoramidic acid isobutyl ester 1-methoxy-vinyl ester manufacturers Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. 1,4-diacetyl-5-hydroxy-7-methoxy-2,6-dimethyl-indole-3-carboxylic acid ethyl ester suppliers Novartis and GSK carried out a swap of its vaccine and cancer drugs back in 2015. GSK paid $5.25 billion to Novartis for its vaccine business, and Novartis sent $16 billion for GSK’s oncology programs. Tafinlar and Mekinist had already been granted FDA approval at the time of that deal, and as a part of that deal, Novartis agreed to divest its own BRAF and MEK inhibitors to avoid creating a monopoly. Acetic acid (2S,4aR)-1,4a-dimethyl-6-oxo-2,3,4,4a,5,6,7,8-octahydro-naphthalen-2-yl ester vendor & factory.
